Dr. Yong-Sung Kim, PhD

Professor, Department of Molecular Science and Technology at Ajou University

Speaker

Dr. Yong-Sung Kim has been a professor of Dept. of Molecular Science and Technology at Ajou University (Suwon, Korea) since 2004. Dr. Kim obtained his M.Sc. in Biotechnology in 1998 from KAIST (Daejon, Korea) and Ph.D. in Pharmaceutical Sciences in 2002 from the University of Colorado, Denver, USA. He did post-doc in Prof. K. Dane Wittrup lab at MIT. He also spent one year (2010-2011) during his Sabbatical at Genentech Inc. (SF, USA).

Dr. Kim’s research focuses on development of next generation antibody platform technology for potent anti-cancer therapeutics, including heterodimeric Fc-based bispecific antibody, solid tumor-penetrating antibody platform, and cytosol-penetrating antibody platform technology. Based on the cellular cytosol-penetrating antibody technology, Dr. Kim co-founded Orum Therapeutics Inc. in 2016. His website is http://antibody.ajou.ac.kr/.